Voyager Therapeutics, Inc.
NASDAQ:VYGR
5.19 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| 132.33 | -46.408 | -71.197 | 36.741 | -43.597 | -88.288 | -70.698 | -40.193 | -29.672 | -16.317 | -7.666 |
| Depreciation & Amortization
| 4.441 | 6.191 | 5.165 | 3.817 | 2.765 | 2.117 | 1.595 | 0.612 | 0.6 | 0.184 | 0 |
| Deferred Income Tax
| 0 | 0 | 0.349 | 0.027 | -3.584 | -2.163 | -0.024 | 0.696 | 0.452 | 0 | 0 |
| Stock Based Compensation
| 11.153 | 9.344 | 11.324 | 14.934 | 15.64 | 15.71 | 9.238 | 6.31 | 4.027 | 0.425 | 0 |
| Change In Working Capital
| -66.557 | 20.471 | 3.294 | -144.537 | 78.438 | 55.381 | -2.135 | -12.848 | 56.142 | 0.477 | 0.182 |
| Accounts Receivables
| -83.234 | 0.475 | 7.28 | 10.484 | -18.496 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | -2.205 | -0.909 | 13.505 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.962 | 1.992 | -0.06 | -3.436 | 2.598 | -0.282 | 0.47 | -0.062 | -0.942 | 0.604 | 0 |
| Other Working Capital
| 17.639 | 18.004 | -1.721 | -150.676 | 80.831 | 55.663 | -2.605 | -12.786 | 57.084 | -0.127 | 0.182 |
| Other Non Cash Items
| -3.448 | -2.107 | -2.46 | -7.698 | -0.996 | 1.356 | 0.674 | 2.941 | 9.75 | 3.313 | 2.034 |
| Operating Cash Flow
| 77.919 | -12.509 | -53.525 | -96.716 | 48.666 | -15.887 | -61.35 | -42.482 | 41.299 | -11.918 | -5.45 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -3.256 | -2.491 | -1.609 | -12.097 | -7.718 | -4.305 | -3.985 | -5.029 | -1.03 | -2.988 | 0 |
| Acquisitions Net
| 138.387 | 4.848 | -2.46 | -7.698 | 0.172 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -223.968 | -54.848 | -15.117 | -70.403 | -494.231 | -333.228 | -147.296 | -112.35 | -220.399 | 0 | 0 |
| Sales Maturities Of Investments
| 85.581 | 50 | 82.632 | 195.495 | 411.3 | 364 | 147.6 | 165.1 | 26.66 | 0 | 0 |
| Other Investing Activites
| -138.387 | -4.848 | 2.46 | 7.698 | -82.759 | 30.772 | 0.304 | -0.421 | -193.739 | -0.314 | 0 |
| Investing Cash Flow
| -141.643 | -7.339 | 65.906 | 112.995 | -90.477 | 26.467 | -3.681 | 47.3 | -194.769 | -3.302 | 0 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 31.121 | 1.11 | 0.612 | 3.163 | 77.617 | 4.749 | 57.994 | 0.514 | 104.779 | 0.08 | 0 |
| Common Stock Repurchased
| 0 | 0.481 | 0.584 | 0.844 | 0 | 0.86 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 2.524 | 1.11 | 0.612 | 3.163 | 3.377 | 4.749 | 1.926 | 0.514 | 177.734 | 44.16 | 5.72 |
| Financing Cash Flow
| 33.645 | 1.11 | 0.612 | 3.163 | 80.994 | 4.749 | 59.92 | 0.514 | 177.744 | 22.12 | 5.72 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -30.079 | -18.738 | 12.993 | 19.442 | 39.183 | 15.329 | -5.111 | 5.332 | 24.274 | 6.9 | 0.27 |
| Cash At End Of Period
| 70.395 | 100.474 | 119.212 | 106.219 | 86.777 | 47.594 | 31.53 | 36.641 | 31.309 | 7.035 | 0.27 |